CDKN2A and glioma: A recent investigation of 100 IDH-wt and IDH-mut gliomas cases showed a good correlation between p16 immunostaining and the presence of homozygous CDKN2A deletions across IDH-wt and IDH-mut tumors of all WHO grades.